RecruitingNot ApplicableNCT06831253
Efficacy of Platelet-Rich Plasma Injection in Dry Eye Syndrome
Efficacy of Restoration of Lacrimal Secretion After Injection of Platelet-Rich Plasma (PRP) Into the Lacrimal Gland in Severe Dry Eye Syndromes (ReLIPSSO)
Sponsor
Centre Hospitalier Universitaire de Nice
Enrollment
20 participants
Start Date
Mar 17, 2025
Study Type
INTERVENTIONAL
Conditions
Summary
The investigatror wants to show the efficacy of Platelet-Rich Plasma injection in lacrimal gland to restore the lacrimal secretion in patients presenting aqueous deficiency reponsible for severe dry eye syndrome.
Eligibility
Min Age: 18 Years
Inclusion Criteria2
- Platelet counts, and clotting factors in the standarts
- Presenting with severe dry keratoconjunctivitis diagnosed by an ophthalmologist
Exclusion Criteria2
- Patients with significant fibrosis of the conjunctival portion of the lacrimal gland
- Patients with complete stenosis of both lacrimal meatus in the treated eye
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
OTHERinjections of Platelet-Rich Plasma in lacrimal gland
injections of Platelet-Rich Plasma in lacrimal gland
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06831253
Related Trials
Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD
NCT062204742 locations
Clinical Investigation Between the Topical Administration of a Tear Substitute With Ancillary Medicinal Substance and Hyaluronic Acid 0.3% (FBV_01) vs Hyaluronic Acid 0.3% in Subjects in the Treatment From Moderate to Severe DED
NCT074128602 locations
Protecting the Eyes of Gamers With Lubricating Eyedrops
NCT061639891 location
Photobiomodulation With REd vs BluE Light (REBEL)
NCT063713002 locations
Three-dimensional Analysis of EMMPRIN on Conjunctival Epithelial Cells Surface in Severe Dry Eye Syndrome (ALTESSE)
NCT033589791 location